Eterna Therapeutics Inc

ERNA · NASDAQ · Healthcare / Biotechnology

1.68USD-0.11 (-6.15%)

Price History

Full chart

Market Stats

Previous Close1.79

Open1.82

Day Range1.67 – 1.94

52-Week Range3.18 – 48.00

Volume28.25K

Market Cap4.02M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.41

Dividend Yield0.00%

Beta2.62

50-Day Avg4.32

200-Day Avg11.18

About

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Sanjeev Luther
Employees5
Headquarters1035 Cambridge Street, Cambridge, MA, United States, 02141, USA
Websitehttps://www.ernexatx.com

Leadership

Mr. Sanjeev LutherCEO, President & Director · b. 1962

Financials

Income Statement

Currency: USD	2006-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	32.98M	25.81M	25.31M	23.87M	24.06M	23.75M	26.05M	24.52M	22.31M	21.27M	23.34M	19.81M	5.80M	0	0	68.00K	582.00K	0
Growth (%)	-	-21.74%	-1.96%	-5.69%	+0.81%	-1.31%	+9.67%	-5.86%	-9.00%	-4.65%	+9.69%	-15.12%	-70.72%	-100.00%	-	-	+755.88%	-100.00%
Cost of Revenue	-	919.00K	665.00K	891.00K	721.00K	733.00K	605.00K	13.06M	8.13M	7.09M	8.38M	7.84M	98.00K	459.00K	497.00K	236.00K	96.00K	263.00K
Gross Profit	32.98M	24.89M	24.64M	22.98M	23.34M	23.02M	25.44M	11.46M	14.18M	14.19M	14.95M	11.96M	-98.00K	-459.00K	-497.00K	-168.00K	486.00K	-263.00K
Gross Margin	100.00%	96.44%	97.37%	96.27%	97.00%	96.91%	97.68%	46.74%	63.55%	66.68%	64.07%	60.40%	-1.69%	-	-	-247.06%	83.51%	-
Operating Expense	34.34M	26.40M	24.97M	26.25M	24.41M	24.14M	30.18M	18.06M	16.46M	15.59M	14.49M	13.18M	7.15M	113.27M	32.72M	20.97M	16.16M	9.06M
Operating Income	-1.36M	-1.50M	-325.00K	-3.28M	-1.06M	-1.12M	-4.74M	-6.60M	-2.28M	-1.40M	464.00K	-1.21M	-7.25M	-113.73M	-33.22M	-21.14M	-15.67M	-9.32M
Operating Margin	-4.12%	-5.81%	-1.28%	-13.72%	-4.41%	-4.71%	-18.21%	-26.92%	-10.21%	-6.59%	1.99%	-6.12%	-124.97%	-	-	-31080.88%	-2693.13%	-
EBITDA	-	4.80M	5.52M	2.17M	5.20M	6.56M	5.81M	-3.63M	609.00K	915.00K	3.23M	1.40M	-26.39M	-121.95M	-24.01M	-19.93M	-36.12M	-13.84M
EBITDA Margin	-	18.59%	21.81%	9.10%	21.61%	27.63%	22.31%	-14.79%	2.73%	4.30%	13.83%	7.05%	-455.00%	-	-	-29314.71%	-6206.01%	-
Net Income	-4.77M	-1.50M	-400.00K	-3.42M	-995.00K	-1.05M	-5.03M	-7.23M	-2.92M	-1.08M	-259.00K	-2.05M	11.91M	-122.55M	-24.58M	-21.67M	-44.54M	-14.08M
Net Income Margin	-14.47%	-5.81%	-1.58%	-14.32%	-4.13%	-4.43%	-19.31%	-29.47%	-13.10%	-5.06%	-1.11%	-10.34%	205.28%	-	-	-31864.71%	-7652.75%	-
R&D	-	-	-	-	-	-	-	-	-	139.00K	72.00K	26.00K	3.95M	12.71M	10.39M	5.92M	4.60M	4.16M
R&D as % of Total Revenue	-	-	-	-	-	-	-	-	-	0.65%	0.31%	0.13%	68.12%	-	-	8705.88%	791.07%	-
Interest Expense	-	66.00K	101.00K	52.00K	44.00K	26.00K	223.00K	484.00K	576.00K	498.00K	389.00K	249.00K	43.00K	74.00K	30.00K	614.00K	6.75M	27.00K
Interest Expense % of Total Revenue	-	0.26%	0.40%	0.22%	0.18%	0.11%	0.86%	1.97%	2.58%	2.34%	1.67%	1.26%	0.74%	-	-	902.94%	1160.14%	-

Balance Sheet

Currency: USD	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	26.52M	20.86M	11.66M	14.30M	13.13M	11.65M	12.66M	15.46M	22.27M	16.82M	17.14M	16.57M	14.86M	15.28M	12.91M	31.52M	22.28M	49.13M	5.27M	5.83M
Total Liabilities	8.00M	5.29M	3.92M	4.88M	3.66M	5.30M	4.76M	6.25M	11.34M	12.97M	13.07M	11.03M	7.95M	10.19M	5.25M	6.02M	10.17M	46.90M	3.57M	3.43M
Total Equity	18.53M	15.57M	7.75M	9.42M	9.46M	6.35M	7.89M	9.20M	10.92M	3.85M	4.07M	5.54M	6.92M	5.09M	7.66M	25.50M	12.11M	2.23M	1.70M	2.40M
Cash	-	10.27M	3.36M	3.64M	3.91M	1.37M	2.72M	5.46M	7.18M	3.22M	5.69M	3.38M	2.59M	3.26M	1.63M	16.98M	11.45M	7.58M	1.73M	1.88M
Total Debt	-	7.00K	40.00K	473.00K	481.00K	450.00K	167.00K	1.68M	5.38M	7.65M	8.53M	5.41M	3.81M	6.08M	2.90M	2.72M	4.14M	41.84M	684.00K	490.00K
Net Debt	-	-10.27M	-3.32M	-3.16M	-3.42M	-924.00K	-2.55M	-3.78M	-1.81M	4.43M	2.84M	2.03M	1.23M	2.82M	1.27M	-14.26M	-7.31M	34.27M	-1.04M	-1.39M

Cash Flow

Currency: USD	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-	-604.00M	-	2.50M	2.83M	574.00K	2.16M	1.49M	-6.38M	-4.18M	23.00K	549.00K	1.36M	2.74M	-8.10M	-23.49M	-20.98M	-20.41M	-15.84M	-7.02M
Investing Cash Flow	-	-	-	-	-	-	-	-	-	-1.62M	-840.00K	-1.45M	-1.58M	-1.06M	-39.00K	-22.74M	-47.00K	-19.00K	-365.00K	-37.00K
Financing Cash Flow	9.00K	-	-24.00K	623.00K	-364.00K	-300.00K	1.95M	3.75M	10.08M	1.98M	3.26M	-1.47M	-303.00K	-1.10M	4.67M	61.59M	19.58M	16.56M	6.26M	7.21M
Capital Expenditure	0	0	0	1.91M	1.32M	1.59M	1.23M	861.00K	835.00K	1.63M	840.00K	1.45M	1.61M	1.09M	39.00K	154.00K	297.00K	19.00K	369.00K	37.00K
Free Cash Flow	-	-604.00M	-	593.00K	1.51M	-1.02M	930.00K	632.00K	-7.22M	-5.81M	-817.00K	-903.00K	-247.00K	1.65M	-8.14M	-23.64M	-21.27M	-20.43M	-16.20M	-7.05M
Dividends Paid	-	-	-	-	-	-	-	16.00K	16.00K	16.00K	16.00K	16.00K	16.00K	16.00K	16.00K	8.00K	16.00K	16.00K	16.00K	-
FCF to OCF	-	100.00%	-	23.69%	53.27%	-177.70%	43.14%	42.33%	113.08%	139.04%	-3552.17%	-164.48%	-18.10%	60.13%	100.48%	100.66%	101.42%	100.09%	102.33%	100.53%
Dividend Paid to FCF	-	-	-	-	-	-	-	2.53%	-0.22%	-0.28%	-1.96%	-1.77%	-6.48%	0.97%	-0.20%	-0.03%	-0.08%	-0.08%	-0.10%	-

Earnings

Report Date	Mar 16, 1993	Mar 31, 1998	Jul 1, 1998	Sep 30, 1998	Mar 31, 1999	Jun 30, 1999	Sep 30, 1999	Mar 31, 2000	Jun 30, 2000	Sep 30, 2000	Mar 31, 2001	Jun 30, 2001	Sep 30, 2001	Dec 31, 2001	Mar 31, 2002	Jul 25, 2002	Nov 1, 2002	Apr 30, 2003	Aug 6, 2003	Nov 13, 2003	Mar 15, 2004	May 10, 2004	Jul 29, 2004	Nov 9, 2004	Mar 16, 2005	May 10, 2005	Aug 8, 2005	Nov 8, 2005	Mar 16, 2006	May 9, 2006	Aug 8, 2006	Nov 8, 2006	Mar 14, 2007	May 9, 2007	Aug 8, 2007	Nov 8, 2007	Mar 14, 2008	May 9, 2008	Aug 8, 2008	Nov 7, 2008	Mar 20, 2009	May 15, 2009	Aug 14, 2009	Nov 13, 2009	May 14, 2010	Aug 13, 2010	Nov 11, 2010	Mar 24, 2011	May 11, 2011	Aug 4, 2011	Nov 10, 2011	Mar 29, 2012	May 10, 2012	Aug 13, 2012	Nov 8, 2012	Mar 29, 2013	May 10, 2013	Aug 15, 2013	Nov 14, 2013	Mar 27, 2014	May 14, 2014	Aug 13, 2014	Nov 6, 2014	Mar 26, 2015	May 7, 2015	Aug 6, 2015	Nov 5, 2015	Mar 11, 2016	May 6, 2016	Aug 3, 2016	Nov 8, 2016	Mar 6, 2017	May 3, 2017	Aug 2, 2017	Nov 7, 2017	Mar 6, 2018	May 9, 2018	Aug 2, 2018	Nov 7, 2018	Mar 20, 2019	May 13, 2019	Aug 9, 2019	Oct 10, 2019	Mar 19, 2020	May 19, 2020	Aug 7, 2020	Nov 11, 2020	Mar 11, 2021	May 17, 2021	Aug 13, 2021	Nov 12, 2021	Dec 31, 2021	Apr 15, 2022	Aug 11, 2022	Nov 14, 2022	Mar 20, 2023	May 11, 2023	Aug 11, 2023	Nov 13, 2023	Mar 19, 2024	May 22, 2024	Aug 12, 2024	Nov 29, 2024	Mar 12, 2025	May 7, 2025	Aug 13, 2025	Nov 7, 2025	Mar 24, 2026	May 11, 2026	Aug 12, 2026	Nov 6, 2026
EPS Estimate	-60.00	-	-160.00	-	-	-	-	-	-	-	-	-	-	-	-	-80.00	-	-	-	-	-40.00	-40.00	-	-	-40.00	-40.00	-40.00	-20.00	20.00	6.67	-	-6.67	-	-40.00	-40.00	-20.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-60.00	-40.00	-20.00	-40.00	-20.80	-19.20	-7.60	-15.60	-14.00	-8.40	-5.60	-10.80	-9.20	-1.60	6.00	0.20	-0.03	-0.03	0.01	-	-	-	-	-	-	-600.00	-937.50	-937.50	-975.00	-825.00	-0.14	-0.14	-	-	-	-	-	-	0.00	0.00	0.00	0.00	-	-1.95	-3.30	-3.84
EPS Actual	-140.00	-19357.08	-260.00	-8992.07	-22385.65	-12584.52	12962.54	-4770.49	-56010.11	-26462.60	-32571.90	-19414.89	-14928.62	-7995.65	-3225.05	-40.00	-13158.90	-4686.61	-14076.32	-11440.38	-40.00	-40.00	-15283.76	-17477.49	-60.00	-40.00	-40.00	8.11	5.72	2.49	-60.00	-2.02	-108.28	-20.00	-20.00	-60.00	-26100.67	-34981.06	-31859.68	-11644.86	-13754.55	-3463.17	-3661.58	-9624.86	-4870.62	-5694.66	1528.37	3975.57	-6944.44	-12220.97	-10392.52	-12901.06	-12147.58	-6733.47	567.44	6612.89	-3905.48	-1044.86	-2464.82	-3563.54	-6226.18	-11381.16	-28.80	-37.43	-49.26	-60.00	-20.00	-20.00	-22.40	-18.40	-12.40	-8.80	-1.60	-2.80	-2.80	-10.00	-6.40	-2.00	3.20	4.40	-0.11	-0.03	-0.12	-0.45	0.02	0.02	0.02	0.10	0.02	-0.24	-12749.99	-3.20	-3.20	-450.00	-933.75	-1.24	-1.24	-0.85	-1.03	-427.06	-460.74	-383.80	-1844.09	-0.15	-2.31	-0.61	-0.15	-4.81	-6.95	-3.40	-
Surprise	-133.33%	-	-62.50%	-	-	-	-	-	-	-	-	-	-	-	-	50.00%	-	-	-	-	0.00%	0.00%	-	-	-50.00%	0.00%	0.00%	140.57%	-71.39%	-62.60%	-	69.70%	-	50.00%	50.00%	-200.00%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00%	50.00%	0.00%	44.00%	11.54%	35.42%	-15.79%	89.74%	80.00%	66.67%	-78.57%	40.74%	78.26%	300.00%	-26.67%	-155.00%	0.00%	-300.00%	-4600.00%	-	-	-	-	-	-	-2025.00%	99.66%	99.66%	53.85%	-13.18%	-785.71%	-785.71%	-	-	-	-	-	-	-	-	-	-	-	-256.41%	-3.03%	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	-	-	After-hours	After-hours	After-hours	Pre-market	Pre-market	After-hours	After-hours	After-hours	After-hours	-	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	Pre-market	-	-	-	-	-	-	-	-	-	After-hours	-	-

Key Statistics & Ratios

Market Cap4.02M

Enterprise Value-362.57K

Trailing P/E0.00

Forward P/E0.00

Price / Sales7.23

Price / Book1.35

EPS-0.41

Book Value2.73

Revenue (TTM)1.00K

Gross Profit (TTM)1.00K

EBITDA-11.69M

Profit Margin0.00%

Operating Margin0.00%

Return on Equity-320.72%

Return on Assets-105.57%

Shares Outstanding1.17M

Shares Float1.20M

Beta2.62

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Ownership Breakdown

Institutions: 2.18%
Insiders: 29.82%
Retail / Other: 68.00%

Top Institutional Holders

Citadel Advisors Llc
15.10K0.93%
Geode Capital Management, LLC
244.45K0.60%
Vanguard Capital Management, LLC
26.50K0.06%
Vanguard Fiduciary Trust Co
25.45K0.06%
UBS Group AG
21.23K0.05%
Tradewinds Capital Management, LLC
3610.02%
BlackRock Inc
8200.00%
Genworth Financial Wealth Mgmt Inc
1330.00%
HRT FINANCIAL LLC
00.00%
BNP Paribas Arbitrage, SA
100.00%
A. Montag & Associates Inc
80.00%
SBI Securities Co Ltd
60.00%
Warberg Asset Management LLC
00.00%
CI Private Wealth LLC
00.00%
Fortitude Family Office LLC
00.00%
Sippican Capital Adivsors
00.00%
Morgan Stanley - Brokerage Accounts
00.00%

Top Fund Holders

Fidelity Extended Market Index
5.57K0.34%
Fidelity Series Total Market Index
1.60K0.10%
Cinvest Azero Global FI
5370.03%

Stock Splits

May 4, 20261:25
Jun 12, 20251:15
Oct 17, 20221:20
Mar 26, 20211:2